HUT38249A - Process for producing oral penicilline composition of controlled dissolving the active agents
- Google Patents
Process for producing oral penicilline composition of controlled dissolving the active agents
Info
Publication number
HUT38249A
HUT38249AHU325084AHU325084AHUT38249AHU T38249 AHUT38249 AHU T38249AHU 325084 AHU325084 AHU 325084AHU 325084 AHU325084 AHU 325084AHU T38249 AHUT38249 AHU T38249A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal GyogyszergyarfiledCriticalBiogal Gyogyszergyar
Priority to HU325084ApriorityCriticalpatent/HU192906B/en
Publication of HUT38249ApublicationCriticalpatent/HUT38249A/en
Publication of HU192906BpublicationCriticalpatent/HU192906B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Controlled release penicillin prepns. for oral application contain as one of the active ingredients the dienyl-ethylene-diamine-salt of phenoxy-methyl-penicillin. This penicillin salt has useful adhesive properties and takes part in the formation of the matrix, together with the indifferent solid polymers, allowing a reduction in the quantity of release retarding additives. - The structure of the matrix and hence the rate of release of the penicillin can be controlled by varying the pressure used in making the tablets, and the ratio of solid polymer to the phenoxy-methyl-penicillin -dibenzyl-ethylene-diamine salt. - A single tablet contg. 600.000 i.u. maintains a curative penicillin level in the blood stream for 12 hours.
HU325084A1984-08-301984-08-30Process for producing oral penicilline composition of controlled dissolving the active agents
HU192906B
(en)
Process for the preparation of pharmaceutical compositions having high rate of resorption,from heart glicosides,in se hardly resorptive,to be parenterically administered
Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide